These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33962671)

  • 1. Evaluation of two sexual-stage antigens as bivalent transmission-blocking vaccines in rodent malaria.
    Yang F; Liu F; Yu X; Zheng W; Wu Y; Qiu Y; Jin Y; Cui L; Cao Y
    Parasit Vectors; 2021 May; 14(1):241. PubMed ID: 33962671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dual-antigen malaria vaccine targeting Pb22 and Pbg37 was able to induce robust transmission-blocking activity.
    Gao W; Qiu Y; Zhu L; Yu X; Yang F; Chen M; He G; Liu Y; Cui L; Liu F; Zhu X; Cao Y
    Parasit Vectors; 2023 Dec; 16(1):455. PubMed ID: 38098083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidate.
    Zheng W; Liu F; He Y; Liu Q; Humphreys GB; Tsuboi T; Fan Q; Luo E; Cao Y; Cui L
    Parasit Vectors; 2017 Jan; 10(1):8. PubMed ID: 28057055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Plasmodium berghei Pbg37 as Both a Pre- and Postfertilization Antigen with Transmission-Blocking Potential.
    Liu F; Li L; Zheng W; He Y; Wang Y; Zhu X; Tsuboi T; Cui L; Wang M; Cao Y
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29866905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of PSOP26 as an ookinete surface antigen with improved transmission-blocking activity when fused with PSOP25.
    Wang PP; Jiang X; Bai J; Yang F; Yu X; Wu Y; Zheng W; Zhang Y; Cui L; Liu F; Zhu X; Cao Y
    Parasit Vectors; 2022 May; 15(1):175. PubMed ID: 35606790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of transmission-blocking vaccines simultaneously targeting pre- and post-fertilization antigens in the rodent malaria parasite Plasmodium yoelii.
    Zheng L; Pang W; Qi Z; Luo E; Cui L; Cao Y
    Parasit Vectors; 2016 Aug; 9(1):433. PubMed ID: 27502144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nanoparticle vaccine displaying the ookinete PSOP25 antigen elicits transmission-blocking antibody response against Plasmodium berghei.
    Yao G; Min H; Yu X; Liu F; Cui L; Cao Y
    Parasit Vectors; 2023 Nov; 16(1):403. PubMed ID: 37932796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of transmission-blocking potential of PvPSOP25 using transgenic murine malaria parasite and clinical isolates.
    Zhang B; Feng H; Zhao Y; Zhang D; Yu X; Li Y; Zeng Y; Thongpoon S; Roobsoong W; Wu Y; Liu F; Sattabongkot J; Min H; Cui L; Cao Y
    PLoS Negl Trop Dis; 2024 Jun; 18(6):e0012231. PubMed ID: 38865344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a Plasmodium berghei sexual stage antigen PbPH as a new candidate for malaria transmission-blocking vaccine.
    Kou X; Zheng W; Du F; Liu F; Wang M; Fan Q; Cui L; Luo E; Cao Y
    Parasit Vectors; 2016 Apr; 9():190. PubMed ID: 27038925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Pb51 in Plasmodium berghei as a malaria vaccine candidate targeting both asexual erythrocytic proliferation and transmission.
    Wang J; Zheng W; Liu F; Wang Y; He Y; Zheng L; Fan Q; Luo E; Cao Y; Cui L
    Malar J; 2017 Nov; 16(1):458. PubMed ID: 29132428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites.
    Mizutani M; Iyori M; Blagborough AM; Fukumoto S; Funatsu T; Sinden RE; Yoshida S
    Infect Immun; 2014 Oct; 82(10):4348-57. PubMed ID: 25092912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Plasmodium berghei sexual stage antigen PSOP12 induces anti-malarial transmission blocking immunity both in vivo and in vitro.
    Sala KA; Nishiura H; Upton LM; Zakutansky SE; Delves MJ; Iyori M; Mizutani M; Sinden RE; Yoshida S; Blagborough AM
    Vaccine; 2015 Jan; 33(3):437-45. PubMed ID: 25454088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of three ookinete-specific genes and evaluation of their transmission-blocking potentials in Plasmodium berghei.
    Zheng W; Kou X; Du Y; Liu F; Yu C; Tsuboi T; Fan Q; Luo E; Cao Y; Cui L
    Vaccine; 2016 May; 34(23):2570-8. PubMed ID: 27083421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Viral-Vectored Multi-Stage Malaria Vaccine Regimen With Protective and Transmission-Blocking Efficacies.
    Yusuf Y; Yoshii T; Iyori M; Mizukami H; Fukumoto S; Yamamoto DS; Emran TB; Amelia F; Islam A; Syafira I; Yoshida S
    Front Immunol; 2019; 10():2412. PubMed ID: 31681301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responses.
    Jones RM; Chichester JA; Manceva S; Gibbs SK; Musiychuk K; Shamloul M; Norikane J; Streatfield SJ; van de Vegte-Bolmer M; Roeffen W; Sauerwein RW; Yusibov V
    Hum Vaccin Immunother; 2015; 11(1):124-32. PubMed ID: 25483525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
    Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
    Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A conserved malaria parasite antigen Pb22 plays a critical role in male gametogenesis in Plasmodium berghei.
    Liu F; Yang F; Wang Y; Hong M; Zheng W; Min H; Li D; Jin Y; Tsuboi T; Cui L; Cao Y
    Cell Microbiol; 2021 Mar; 23(3):e13294. PubMed ID: 33222390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology.
    Li Y; Leneghan DB; Miura K; Nikolaeva D; Brian IJ; Dicks MD; Fyfe AJ; Zakutansky SE; de Cassan S; Long CA; Draper SJ; Hill AV; Hill F; Biswas S
    Sci Rep; 2016 Jan; 6():18848. PubMed ID: 26743316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with Transgenic Rodent Malaria Parasites Expressing Pfs25 Induces Potent Transmission-Blocking Activity.
    Sala KA; Angrisano F; Da DF; Taylor IJ; Churcher TS; Blagborough AM
    Sci Rep; 2018 Jan; 8(1):1573. PubMed ID: 29371619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli.
    Chowdhury DR; Angov E; Kariuki T; Kumar N
    PLoS One; 2009 Jul; 4(7):e6352. PubMed ID: 19623257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.